000 | 01831 a2200541 4500 | ||
---|---|---|---|
005 | 20250515062249.0 | ||
264 | 0 | _c20070411 | |
008 | 200704s 0 0 eng d | ||
022 | _a1097-6833 | ||
024 | 7 |
_a10.1016/j.jpeds.2006.11.059 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWarner, Barbara B | |
245 | 0 | 0 |
_aOntogeny of salivary epidermal growth factor and necrotizing enterocolitis. _h[electronic resource] |
260 |
_bThe Journal of pediatrics _cApr 2007 |
||
300 |
_a358-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 | _aApgar Score |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aEnterocolitis, Necrotizing _xepidemiology |
650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGestational Age |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xtherapeutic use |
650 | 0 | 4 | _aInfant Formula |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aInfant, Premature _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMilk, Human |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aOhio _xepidemiology |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRacial Groups _xstatistics & numerical data |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSaliva _xmetabolism |
700 | 1 | _aRyan, Ann Ladd | |
700 | 1 | _aSeeger, Kimberly | |
700 | 1 | _aLeonard, Anthony C | |
700 | 1 | _aErwin, Christopher R | |
700 | 1 | _aWarner, Brad W | |
773 | 0 |
_tThe Journal of pediatrics _gvol. 150 _gno. 4 _gp. 358-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpeds.2006.11.059 _zAvailable from publisher's website |
999 |
_c16936585 _d16936585 |